Clinical Trial Update: Chidamide, Azacitidine Combined With GM Regimen for Relapsed and Refractory DLBCL Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chidamide, azacitidine in combination with GM regimen for relapsed/refractory diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Chidamide (chidamide)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Diffuse Large B-Cell Lymphoma | Phase 2 | Status: UNKNOWN